- Home
- VNDA vs NCA Comparison
VNDA vs NCA Comparison
Compare VNDA & NCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNDA
- NCA
- Stock Information
- Founded
- VNDA 2002
- NCA 1987
- Country
- VNDA United States
- NCA United States
- Employees
- VNDA N/A
- NCA N/A
- Industry
- VNDA Biotechnology: Pharmaceutical Preparations
- NCA Investment Managers
- Sector
- VNDA Health Care
- NCA Finance
- Exchange
- VNDA Nasdaq
- NCA Nasdaq
- Market Cap
- VNDA 282.8M
- NCA 284.4M
- IPO Year
- VNDA 2006
- NCA N/A
- Fundamental
- Price
- VNDA $5.07
- NCA $8.64
- Analyst Decision
- VNDA Strong Buy
- NCA
- Analyst Count
- VNDA 2
- NCA 0
- Target Price
- VNDA $16.50
- NCA N/A
- AVG Volume (30 Days)
- VNDA 778.6K
- NCA 59.6K
- Earning Date
- VNDA 05-07-2025
- NCA 01-01-0001
- Dividend Yield
- VNDA N/A
- NCA 3.92%
- EPS Growth
- VNDA N/A
- NCA N/A
- EPS
- VNDA N/A
- NCA N/A
- Revenue
- VNDA $198,772,000.00
- NCA N/A
- Revenue This Year
- VNDA $14.36
- NCA N/A
- Revenue Next Year
- VNDA $44.53
- NCA N/A
- P/E Ratio
- VNDA N/A
- NCA N/A
- Revenue Growth
- VNDA 3.18
- NCA N/A
- 52 Week Low
- VNDA $3.71
- NCA $7.77
- 52 Week High
- VNDA $6.75
- NCA $9.12
- Technical
- Relative Strength Index (RSI)
- VNDA 58.96
- NCA 52.39
- Support Level
- VNDA $4.84
- NCA $8.58
- Resistance Level
- VNDA $5.07
- NCA $8.71
- Average True Range (ATR)
- VNDA 0.23
- NCA 0.07
- MACD
- VNDA 0.02
- NCA -0.00
- Stochastic Oscillator
- VNDA 70.63
- NCA 41.18
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.
About NCA Nuveen California Municipal Value Fund
Nuveen California Municipal Value Fund Inc is a diversified closed-end management investment company. Its primary objective is to provide current income exempt from regular federal and California income taxes. The fund's secondary objective is to enhance portfolio value relative to the California municipal bond market by investing in tax-exempt California municipal securities that the Fund's investment adviser and/or the Fund's sub-adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.